Hepatitis B Community
INTERLEUKIN-28B GENE POLYMORHISM TEST ON HBV MAY BE VERY USEFULL
About This Community:

This forum is an un-mediated, patient-to-patient forum for questions and support regarding Hepatitis B. Topics in this forum include but are not limited to, Causes, Diagnosis, Family and Relationships, Living With Hepatitis B, Research Updates, Treatment, Success Stories, Support, Symptoms.

Font Size:
A
A
A
Background:
Blank
Blank
Blank
Blank Blank

INTERLEUKIN-28B GENE POLYMORHISM TEST ON HBV MAY BE VERY USEFULL

Title INTERLEUKIN-28B GENE POLYMORHISM MAY AFFECT THE NATURAL COURSE OF HEPATITIS B and DELTA VIRUS INFECTIONS
Speaker: A. Mithat Bozdayi
Author: A.M. Bozdayi1,2*, T. Ozturk1, S. Altuntas1, S.C. Karatayli1, E. Karatayli1, C. Inci1, K. Cinar2, R. Albayrak3, M. Ozkan3, Y. Kendal4, R. Idilman2, C. Yurdaydin1,2
Affiliation: 1Institute of Hepatology, 2Department of Gastroenterology School of Medicine, 3Biometry Genetics Department, Ankara University, Ankara, 4Department of Gastroenterology, Dicle University Faculty of Medicine, Diyarbakir, Turkey. *mithat.***@****
Background and aims: It has been suggested that interleukin-28B (IL-28B) polymorphisms are associated with spontaneous clearance of hepatitis C virus (HCV) and be a strong determinant of sustained virologic response in genotypes 1 to 3 HCV. Effect of IL28B polymorphism in treatment response to interferons and outcome in hepatitis B virus infection is much less investigated. The aim of the current study was to investigate a potential association between several single nucleotide polymorphisms (SNPs) of the IL-28B gene (rs12979860, rs1188122, rs8099917, rs8105790, rs12980275) and the natural course of HBV and hepatitis delta virus (HDV) infections.
Material-methods: The study included the following groups: group 1: 211 patients with HBV infection (49 inactive HBV carriers; 162 chronic HBV patients); group 2: 124 anti HBsAg positive persons and group 3: 103 patients with chronic HDV infection. DNA sequencing results were interpreted statistically with the chi-square test and the independent variables were determined by calculating the corresponding odds ratio (OR) and its 95% confidence interval (95% CI) by means of simple logistic regression.
Results: A significant difference (p< 0.01) between group 2 (anti-HBsAg positive) and group 3 (patients with HDV infection) for
(i) TT genotype of rs12979860
(ii) TG and GG genotypes of rs8099917 and
(iii) CC genotype of rs8105790. Significant differences (p< 0.01) were also detected between group 1 (patients with hepatitis B virus infection) and group 2 (anti-HBsAg positive) for
(i) GG genotype of rs8099917,
(ii) TT and TC genotypes of rs8105790. Interestingly, highly significant differences were observed within group 1 patients (patients with hepatitis B virus infection) between inactive HBV carriers and patients with chronic hepatitis B for
(i) TG and GG genotypes of rs8099917 (p< 0.0001) and
(ii) TT and TC genotypes of rs8105790 (p< 0.0001)
Conclusion: These results suggest that IL-28B polymorphisms may affect the natural history of HBV infection:
(i) it may be associated with the development of natural immunity;
(ii) it is a strong determinant of the inactive HBsAg carrier state;
(iii) it may affect progression to chronic B hepatitis following HBV infection; and
(iv) may also be involved in progression of HDV infection to chronicity.
Related Discussions
Post a Comment
To
Blank
Weight Tracker
Weight Tracker
Start Tracking Now
Hepatitis B Community Resources
RSS Expert Activity
469720_tn?1388149949
Blank
Abdominal Aortic Aneurysm-treatable... Blank
Oct 04 by Lee Kirksey, MDBlank
242532_tn?1269553979
Blank
The 3 Essentials to Ending Emotiona...
Sep 18 by Roger Gould, M.D.Blank
242532_tn?1269553979
Blank
Control Emotional Eating with this ...
Sep 04 by Roger Gould, M.D.Blank
Top Hepatitis Answerers
Avatar_m_tn
Blank
stef2011
Italy
Avatar_m_tn
Blank
StephenCastlecrag
Australia
9624973_tn?1413019730
Blank
melcul
United Kingdom
Avatar_m_tn
Blank
mike9111
MI
Avatar_m_tn
Blank
luckyman316
Avatar_m_tn
Blank
veteranB
CA